SlideShare ist ein Scribd-Unternehmen logo
1 von 4
Downloaden Sie, um offline zu lesen
India Research
Sector: FMCG
CCL Products Ltd.
The company recently released its Q1FY15 results. The results are a
testimony to the management’s strategy of profitable growth. The
company has enumerated the following focal points which will drive
growth in the future:
o Firstly in domestic markets the company plans to expand its
presence of its retail brand ‘Continental Coffee”. Priced at a
premium this is offering is not a head along war with Nestle & HUL.
The product is a freeze dried offering as compared to the existing
offerings of instant coffee in India (are primarily spray dried coffee).
Over the next 2 to 3 years CCL wants ~ 15% of the existing capacity
in India to be used for domestic markets.The domestic markets are
much more profitable as well.
o Secondly, in Vietnam the company is expected to reach 50% capacity
utilization in FY15. Strong Demand coupled with cost savings on
account of local procurement of raw bean has enabled the company
to be competitively present in the market. Q1 saw profit out of
Vietnam operations. These operations enjoy a 4 year tax holiday and
as the contribution from this region increases going forward the tax
saving will enable profits to grow at a higher rate.The company plans
to double the capacity to 20,000 MT for the Vietnamese operations
next fiscal with minimum capex as the foundation was already setup
when the first has was being setup. This too will add volumes and
scale to CCL operations over the next 2 years.
Result Highlights:
Standalone net sales grew by 4.2% YOY to `132.6 crs driven primarily by
volumes.Volumes were up 9.6% to 3125 MT from 2850 MT corresponding
quarter last year. Being a lean quarter (summer months globally) the mix
was tilted towards the sub-premium quality of coffee. Realizations per kg
were 5% lower at `424/kg vs. `447 per/kg. On a consolidated basis net
sales grew by 29.5% to `175.6 crs. Subsidiaries sales were up 400%YOY to
`43 crs. Vietnamese operations picked up passed with production of
~1150 MT this quarter and volumes sale of ~900 MT. Realizations were
in the range of `400-440/ kg in Vietnam. For FY15 the company expects
consolidated volumes of ~20,000 MT in which Vietnam will
contribute ~5000 MT. We expect topline to grow at ~20-22% CAGR
over the next 2 to 3 years.
On the operating level the mix adversely impacted the margins. Operating
profit in standalone operations was down from `27.7 crs to `25.3 crs.
Operating margins contracted by 280 bps to 19%. Seasonality in demand in
export markets as well as Re./$ translation impacted profitability growth. .
Consolidated EBIDTA for Q1FY15 grew by 19.5% to `36 crs with margins
contracting by 170 bps to 20.5%. Margins in the subsidiaries were at ~25%
with absolute level operating profit at ~`10 crs. On the PAT Level
standalone operations was flat at `15.7 crs as tax rate for the quarter was
Result Update Q1FY15
Date 30th July 2014
CMP `69.2/-
52 week High / Low `75.7/`24.1
Equity Cap (current) `26.6 crs
FaceValue `2/-
Mkt. Capitalization `920 crs.
BSE SENSEX 25,991.23
NSE - NIFTY 7,748.70
NSE Code CCL
Bloomberg Code CCL IN
BSE Code 519600
Shareholding Pattern @ 30-06-14
Promoters 44.54%
FII & DFI 9.17%
Public & Others 46.30%
3-MTS 6-MTS 1-YR
CCL 28.1% 57.2% 172.0%
Sensex 15.7% 24.1% 37.6%
Nifty 15.4% 24.5% 39.6%
Brief Financials FY13A FY14A FY15E
Net Sales 650.7 716.8 862.2
Sales growth 10.2% 20.3%
EBITDA 121.3 143.1 180.5
EBITDAM 18.6% 20.0% 20.9%
PAT 47.5 64.4 96.2
EPS 3.6 4.8 7.2
P/E (x) 19.7 14.5 9.6
Nilesh Doshi
Tel: +9122-66638950
Nilesh.doshi@tssl.in
Accumulate
CCL Products Ltd. – Q1FY15 2 30th
July2014
India Research
Sector: FMCG
lower. Consolidated PAT grew much faster at 587% to `20 crs. on the ack
of Vietnamese operations breaking even on the PAT level. We expect
Operating profit margins to remain in range of 19-20%. PAT will grow
much faster as Vietnamese operations ramp up and become PAT
positive.The tax holiday will further perk up growth. We expect PAT
to grow by ~35-40% for the next 2 to 3 years.
Outlook &Valuations:
We believe the growth levers for CLL products to be well placed. The
company’s focus on growing its presence in the domestic market with a
strong brand coupled with ramp-up ofVietnamese operations will pave the
road to healthy profitable growth for the next 2-3 years. At the CMP of
````69.2/- the stock trades at 9.6x its FY15E estimated EPS of ````7.2/-.
We recommend investors to ACCUMULATE the stock.
Quarterly Results
CCL Products Ltd. – Q1FY15 3 30th
July2014
India Research
Sector: FMCG
(` Cr.)
(YE March 31) STANDALONE CONSOLIDATED
Q1FY
15
Q1FY
14
%
Chg.
FY14 FY13
%
Chg.
Q1FY
15
Q1FY
14
%
Chg.
FY14 FY13
%
Chg.
Net Sales 132.6 127.2 4.2% 611.1 584.8 4.5% 175.6 135.6 29.5% 716.8 650.7 10.2%
Other operational
Income
Total Oper.
Income(TOI)
132.6 127.2 4.2% 611.1 584.8 4.5% 175.6 135.6 29.5% 716.8 650.7 10.2%
Raw Materials Cons. 84.1 72.1 16.6% 357.3 353.3 1.1% 114.1 82.1 39.0% 420.0 396.7 5.9%
% to TOI 63.4% 56.7% 58.5% 60.4% 65.0% 60.6% 58.6% 61.0%
Stock adj. (-)Inc /
(+)Dec
-2.7 -5.8 -53.6% -2.1 -0.4 445.6% -8.5 -13.5 -37.4% 5.1 -12.2
% to TOI -2.0% -4.5% -0.3% -0.1% -4.8% -10.0% 0.7% -1.9%
Net Raw Mat adj. for
stock
81.4 66.4 22.7% 355.2 352.9 0.7% 105.7 68.6 54.0% 425.1 384.5 10.5%
% to TOI 61.4% 52.2% 58.1% 60.3% 60.2% 50.6% 59.3% 59.1%
Personnel 5.1 4.7 7.3% 21.9 17.5 25.2% 6.1 5.5 10.0% 25.8 21.2 21.7%
% to TOI 3.8% 3.7% 3.6% 3.0% 3.5% 4.1% 3.6% 3.3%
Packing Material
Consumed
6.7 7.2 -7.7% 33.0 32.8 0.5% 7.3 7.4 -1.7% 34.6 33.8 2.3%
% to TOI 5.0% 5.7% 5.4% 5.6% 4.2% 5.5% 4.8% 5.2%
Power & Fuel 7.9 7.6 3.5% 38.7 40.0 -3.1% 10.5 8.6 22.3% 45.6 44.1 3.5%
% to TOI 5.9% 6.0% 6.3% 6.8% 6.0% 6.4% 6.4% 6.8%
Other expenses 6.4 13.6 -53.4% 34.8 34.5 1.0% 10.1 15.3 -34.4% 42.6 45.8 -7.0%
% to TOI 4.8% 10.7% 5.7% 5.9% 5.7% 11.3% 5.9% 7.0%
Total expenditure 107.3 99.5 7.9% 483.6 477.6 1.3% 139.7 105.5 32.4% 573.7 529.4 8.4%
Operating Profit 25.3 27.7 -8.8% 127.5 107.3 18.9% 36.0 30.1 19.5% 143.1 121.3 18.0%
OPM (%) 19.0% 21.8% 20.9% 18.3% 20.5% 22.2% 20.0% 18.6%
Non-Operating
Income
0.4 0.1 278.1% 0.9 1.4 -35.8% 0.9 0.2 356.5% 2.6 1.9 40.2%
Interest 1.9 2.1 -13.5% 7.3 12.0 -39.1% 4.2 3.8 10.0% 17.1 20.7 -17.4%
Depreciation 2.4 3.5 -31.1% 13.0 15.9 -18.4% 6.7 6.8 -2.0% 29.1 28.6 1.6%
PBT before Extra-
ord
21.4 22.2 -3.5% 108.2 80.8 33.9% 25.9 19.6 32.1% 99.6 73.9 34.8%
PBT (%) 16.1% 17.4% 17.7% 13.8% 14.7% 14.4% 13.9% 11.4%
PBT 21.4 22.2 -3.5% 108.2 80.8 33.9% 25.9 19.6 32.1% 99.6 73.9 34.8%
Prov. for Tax- Cur 5.8 6.6 -11.8% 34.5 25.1 37.7% 5.8 6.6 -11.8% 34.7 25.2 37.5%
Tax/PBT (%) 27.2% 29.8% 31.9% 31.0% 22.5% 33.7% 34.9% 34.2%
Profit after Cur. Tax 15.6 15.6 0.0% 73.7 55.8 32.1% 20.1 13.0 54.4% 64.9 48.6 33.3%
Prov. for Tax- Def -0.1 0.3
-
154.7%
0.4 1.2 -62.4% -0.1 0.3
-
154.0%
0.4 1.2 -62.4%
Profit after Tax 15.7 15.3 2.6% 73.3 54.6 34.2% 20.2 12.7 58.7% 64.4 47.5 35.7%
PAT (%) 11.84% 12.03% 11.99% 9.33% 11.51% 9.39% 8.99% 7.29%
Share of Profit/(Loss)
of Associates
Minority Interest
Reported PAT 15.7 15.3 2.6% 73.3 54.6 34.2% 20.2 12.7 58.7% 64.4 47.5 35.7%
PAT (adj. For
extraord)
15.7 15.3 2.6% 73.3 54.6 34.2% 20.2 12.7 58.7% 64.4 47.5 35.7%
Face Value 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Equity Share capital 26.6 26.6 26.6 26.6 26.6 26.6 26.6 26.6
No. of shares (in crs.) 13.3 13.3 13.3 13.3 13.3 13.3 13.3 13.3
EPS (````) 1.2 1.2 2.6% 5.5 4.1 34.2% 1.5 1.0 58.7% 4.8 3.6 35.7%
CCL Products Ltd. – Q1FY15 4 30th
July2014
India Research
Sector: FMCG
Team
Analyst Designation Sector Email Telephone
Nilesh Doshi President (Research) nilesh.doshi@tssl.in +9122-6633 8950
ShivaniV.Vishwanathan Sr. Research Analyst FMCG shivani.mehra@tssl.in +9122-6663 8956
Nisha Harchekar Sr. Research Analyst Chemicals nishaharchekar@way2wealth.com +9122-6146 2952
Institutional Dealing Designation Email Telephone
Ajay Prabhudesai AssistantVice President ajay.prabhudesai@tssl.in +9122-4027 8930
Mitul Doshi Senior Executive mitul.doshi@tssl.in +9122-4027 8932
GautamVyas Institutional Sales Trader gautam.vyas@tssl.in +9122-4027 8934
Corporate Office:
3rd Floor, Hincon House,Tower - B, 247 Park, L.B.S. Marg,Vikhroli (W), Mumbai, Maharashtra – 400083, India.
Tel No. 91-22 – 6663 8900 Email: research@tssl.in
website: www.technoworld.in,
www.way2wealth.com
Strictly for Private Circulation only.All rights reserved. ©Techno Shares & Stocks Ltd & Way2Wealth Brokers Pvt. Ltd.
DISCLAIMER: This information & opinions in this report have been prepared by TECHNO SHARES & STOCKS LTD &WAY2WEALTH BROKERS
PVT. LTD.The report & the information contained herein are strictly confidential and meant solely for the authorized recipient and may be restricted
by law or regulation in certain countries.This report is for information purposes only for the authorized reader and does not construe to be any
investment, legal or taxation advice. This report is based on the information obtained from public sources and sources believed to be reliable,
however, no warranty, express or implied, are given for the accuracy or correctness of the same and it should not be construed as such. It is also not
intended as an offer or solicitation for the purchase and sale of any financial instrument.
Techno Shares & Stocks Ltd &Way2Wealth Brokers Pvt. Ltd. and/or its subsidiaries and/or directors, employees, officers or associates – including the
persons involved in the preparation/issuance of this report may have (a) from time to time, any interest or positions (buy/sell etc.) – financial
(including in derivatives/commodities market) or otherwise in the companies/securities covered/mentioned in this report and may have acted upon
the information &/or (b) been engaged in any other transaction, commercial or otherwise, in respect of the companies/securities covered in this
report, like earning brokerage, commission or act as a market maker &/or (c) performed or may seek to perform any merchant/investment banking
services for such companies or act as advisor or lender/borrower to such companies &/or (d) have other possible conflict of interest with respect
to any recommendation or any information/opinions that could affect the objectivity of this report. As a result, the authorized recipients of this
report should rely on their own investigations and analysis & seek professional advice. Any action taken by any one solely on the basis of the
information contained herein is their own responsibility alone and Techno Shares & Stocks Ltd,Way2Wealth Brokers Pvt. Ltd. and its subsidiaries or
its directors, employees or associates will not be liable in any manner whatsoever for the consequences of such action taken.
No data/information contained in this report shall be copied, forwarded, transmitted or distributed, in part or in whole, in any
form or in any media, without the previous written consent ofTechno Shares & Stocks Ltd. &Way2Wealth Brokers Pvt. Ltd.

Weitere ähnliche Inhalte

Was ist angesagt?

CMC Analysts 20Presentation 20- 20FY%2005
CMC Analysts 20Presentation 20- 20FY%2005CMC Analysts 20Presentation 20- 20FY%2005
CMC Analysts 20Presentation 20- 20FY%2005finance21
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; HoldIndiaNotes.com
 
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldHSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldIndiaNotes.com
 
The Quarter One Update for GHCL
The Quarter One Update for GHCLThe Quarter One Update for GHCL
The Quarter One Update for GHCLKritiSahani
 
Bajaj Auto: Margins disappoint as discover woes continue
Bajaj Auto: Margins disappoint as discover woes continueBajaj Auto: Margins disappoint as discover woes continue
Bajaj Auto: Margins disappoint as discover woes continueIndiaNotes.com
 
Bharti airtel ventura_090213
Bharti airtel ventura_090213Bharti airtel ventura_090213
Bharti airtel ventura_090213prasoonster
 
Lumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buyLumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buyIndiaNotes.com
 
Tepid consumer demand means notable recovery in volume growth is quarters away
Tepid consumer demand means notable recovery in volume growth is quarters awayTepid consumer demand means notable recovery in volume growth is quarters away
Tepid consumer demand means notable recovery in volume growth is quarters awayIndiaNotes.com
 
Bharti Airtel 1QFY15 revenue above estimates; buy
 Bharti Airtel 1QFY15 revenue above estimates; buy Bharti Airtel 1QFY15 revenue above estimates; buy
Bharti Airtel 1QFY15 revenue above estimates; buyIndiaNotes.com
 
Global Digital Transformation Partner 2019
Global Digital Transformation Partner 2019Global Digital Transformation Partner 2019
Global Digital Transformation Partner 2019Mr Nyak
 
LinkedIn Q1 2016 Earnings Call
LinkedIn Q1 2016 Earnings CallLinkedIn Q1 2016 Earnings Call
LinkedIn Q1 2016 Earnings CallLinkedIn
 
TOG Oppday 60Q1 17/05/2017
TOG Oppday 60Q1 17/05/2017TOG Oppday 60Q1 17/05/2017
TOG Oppday 60Q1 17/05/2017Share Rora
 
TSR Oppday60Q1 30/5/2017
TSR Oppday60Q1 30/5/2017TSR Oppday60Q1 30/5/2017
TSR Oppday60Q1 30/5/2017Share Rora
 
2 q14 arezzo_apresentacao_call eng
2 q14 arezzo_apresentacao_call eng2 q14 arezzo_apresentacao_call eng
2 q14 arezzo_apresentacao_call engArezzori
 
TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
 TVS Motor Q1FY15: Business outlook strong; New launch impacts margins TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
TVS Motor Q1FY15: Business outlook strong; New launch impacts marginsIndiaNotes.com
 
Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15EIndiaNotes.com
 

Was ist angesagt? (20)

CMC Analysts 20Presentation 20- 20FY%2005
CMC Analysts 20Presentation 20- 20FY%2005CMC Analysts 20Presentation 20- 20FY%2005
CMC Analysts 20Presentation 20- 20FY%2005
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 
Apar Industries_Q2FY15_Nov'14_Eisec
Apar Industries_Q2FY15_Nov'14_EisecApar Industries_Q2FY15_Nov'14_Eisec
Apar Industries_Q2FY15_Nov'14_Eisec
 
Bata india
Bata indiaBata india
Bata india
 
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; HoldHSIL Q4FY15: Disappointing growth but margins maintained; Hold
HSIL Q4FY15: Disappointing growth but margins maintained; Hold
 
The Quarter One Update for GHCL
The Quarter One Update for GHCLThe Quarter One Update for GHCL
The Quarter One Update for GHCL
 
Bajaj Auto: Margins disappoint as discover woes continue
Bajaj Auto: Margins disappoint as discover woes continueBajaj Auto: Margins disappoint as discover woes continue
Bajaj Auto: Margins disappoint as discover woes continue
 
Bharti airtel ventura_090213
Bharti airtel ventura_090213Bharti airtel ventura_090213
Bharti airtel ventura_090213
 
Lumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buyLumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buy
 
Tepid consumer demand means notable recovery in volume growth is quarters away
Tepid consumer demand means notable recovery in volume growth is quarters awayTepid consumer demand means notable recovery in volume growth is quarters away
Tepid consumer demand means notable recovery in volume growth is quarters away
 
Bharti Airtel 1QFY15 revenue above estimates; buy
 Bharti Airtel 1QFY15 revenue above estimates; buy Bharti Airtel 1QFY15 revenue above estimates; buy
Bharti Airtel 1QFY15 revenue above estimates; buy
 
Global Digital Transformation Partner 2019
Global Digital Transformation Partner 2019Global Digital Transformation Partner 2019
Global Digital Transformation Partner 2019
 
LinkedIn Q1 2016 Earnings Call
LinkedIn Q1 2016 Earnings CallLinkedIn Q1 2016 Earnings Call
LinkedIn Q1 2016 Earnings Call
 
TOG Oppday 60Q1 17/05/2017
TOG Oppday 60Q1 17/05/2017TOG Oppday 60Q1 17/05/2017
TOG Oppday 60Q1 17/05/2017
 
Piaggio Group - First Nine Months 2011 Financial Results
Piaggio Group - First Nine Months 2011 Financial ResultsPiaggio Group - First Nine Months 2011 Financial Results
Piaggio Group - First Nine Months 2011 Financial Results
 
TSR Oppday60Q1 30/5/2017
TSR Oppday60Q1 30/5/2017TSR Oppday60Q1 30/5/2017
TSR Oppday60Q1 30/5/2017
 
2 q14 arezzo_apresentacao_call eng
2 q14 arezzo_apresentacao_call eng2 q14 arezzo_apresentacao_call eng
2 q14 arezzo_apresentacao_call eng
 
Equity weekly
Equity weeklyEquity weekly
Equity weekly
 
TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
 TVS Motor Q1FY15: Business outlook strong; New launch impacts margins TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
TVS Motor Q1FY15: Business outlook strong; New launch impacts margins
 
Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15E
 

Ähnlich wie CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate

Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic PharmaIndiaNotes.com
 
Alembic Pharma Q1FY15: EBITDA margins improved by ~285 bps y-o-y; Hold
 Alembic Pharma Q1FY15: EBITDA margins improved by ~285 bps y-o-y; Hold Alembic Pharma Q1FY15: EBITDA margins improved by ~285 bps y-o-y; Hold
Alembic Pharma Q1FY15: EBITDA margins improved by ~285 bps y-o-y; HoldIndiaNotes.com
 
Q1FY16 Results: Granules India posts good results at profitability level
Q1FY16 Results: Granules India posts good results at profitability levelQ1FY16 Results: Granules India posts good results at profitability level
Q1FY16 Results: Granules India posts good results at profitability levelIndiaNotes.com
 
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecJyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecIndiaNotes.com
 
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangIndiaNotes.com
 
TCS Q1FY15: Results in-line, buy on dips
TCS Q1FY15: Results in-line, buy on dipsTCS Q1FY15: Results in-line, buy on dips
TCS Q1FY15: Results in-line, buy on dipsIndiaNotes.com
 
Dabur Q3FY15: Mixed quarter; maintain neutral
 Dabur Q3FY15: Mixed quarter; maintain neutral Dabur Q3FY15: Mixed quarter; maintain neutral
Dabur Q3FY15: Mixed quarter; maintain neutralIndiaNotes.com
 
Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationJigar Savla
 
Marico 1QFY15 results ahead of expectations; buy - Motilal Oswal
Marico 1QFY15 results ahead of expectations; buy - Motilal OswalMarico 1QFY15 results ahead of expectations; buy - Motilal Oswal
Marico 1QFY15 results ahead of expectations; buy - Motilal OswalIndiaNotes.com
 
Zensar Technologies Q1FY15: Results in line with our expectations, buy
 Zensar Technologies Q1FY15: Results in line with our expectations, buy Zensar Technologies Q1FY15: Results in line with our expectations, buy
Zensar Technologies Q1FY15: Results in line with our expectations, buyIndiaNotes.com
 
20230404 Camil Institutional Presentation
20230404 Camil Institutional Presentation20230404 Camil Institutional Presentation
20230404 Camil Institutional PresentationCAMILRI
 
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndiaNotes.com
 
Ccall 1 q12_ing
Ccall 1 q12_ingCcall 1 q12_ing
Ccall 1 q12_ingItauRI
 
Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook
 Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook
Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlookIndiaNotes.com
 
RR - Technicals 1.pdf
RR - Technicals 1.pdfRR - Technicals 1.pdf
RR - Technicals 1.pdfmerag76668
 
Ccall 4 q11_ing
Ccall 4 q11_ingCcall 4 q11_ing
Ccall 4 q11_ingItauRI
 
ITC 1QFY15 results largely in-line; buy
 ITC 1QFY15 results largely in-line; buy ITC 1QFY15 results largely in-line; buy
ITC 1QFY15 results largely in-line; buyIndiaNotes.com
 

Ähnlich wie CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate (20)

Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 
Alembic Pharma Q1FY15: EBITDA margins improved by ~285 bps y-o-y; Hold
 Alembic Pharma Q1FY15: EBITDA margins improved by ~285 bps y-o-y; Hold Alembic Pharma Q1FY15: EBITDA margins improved by ~285 bps y-o-y; Hold
Alembic Pharma Q1FY15: EBITDA margins improved by ~285 bps y-o-y; Hold
 
Q1FY16 Results: Granules India posts good results at profitability level
Q1FY16 Results: Granules India posts good results at profitability levelQ1FY16 Results: Granules India posts good results at profitability level
Q1FY16 Results: Granules India posts good results at profitability level
 
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC SecJyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
Jyothy Laboratories Q1FY15: Buy at CMP - HDFC Sec
 
Varun Beverages Equity Research & Valuation | School of Market Studies Webina...
Varun Beverages Equity Research & Valuation | School of Market Studies Webina...Varun Beverages Equity Research & Valuation | School of Market Studies Webina...
Varun Beverages Equity Research & Valuation | School of Market Studies Webina...
 
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
 
TCS Q1FY15: Results in-line, buy on dips
TCS Q1FY15: Results in-line, buy on dipsTCS Q1FY15: Results in-line, buy on dips
TCS Q1FY15: Results in-line, buy on dips
 
Dabur Q3FY15: Mixed quarter; maintain neutral
 Dabur Q3FY15: Mixed quarter; maintain neutral Dabur Q3FY15: Mixed quarter; maintain neutral
Dabur Q3FY15: Mixed quarter; maintain neutral
 
Vivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 PresentationVivimed labs ltd_3QFY15 Presentation
Vivimed labs ltd_3QFY15 Presentation
 
Marico 1QFY15 results ahead of expectations; buy - Motilal Oswal
Marico 1QFY15 results ahead of expectations; buy - Motilal OswalMarico 1QFY15 results ahead of expectations; buy - Motilal Oswal
Marico 1QFY15 results ahead of expectations; buy - Motilal Oswal
 
Zensar Technologies Q1FY15: Results in line with our expectations, buy
 Zensar Technologies Q1FY15: Results in line with our expectations, buy Zensar Technologies Q1FY15: Results in line with our expectations, buy
Zensar Technologies Q1FY15: Results in line with our expectations, buy
 
20230404 Camil Institutional Presentation
20230404 Camil Institutional Presentation20230404 Camil Institutional Presentation
20230404 Camil Institutional Presentation
 
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; AccumulateIndusInd Bank delivers strong set of numbers in Q4; Accumulate
IndusInd Bank delivers strong set of numbers in Q4; Accumulate
 
Ccall 1 q12_ing
Ccall 1 q12_ingCcall 1 q12_ing
Ccall 1 q12_ing
 
Green cross fy2015
Green cross fy2015Green cross fy2015
Green cross fy2015
 
Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook
 Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook
Blue Star Infotech Q1FY15: Revenues grow 13% y-o-y; Positive outlook
 
RR - Technicals 1.pdf
RR - Technicals 1.pdfRR - Technicals 1.pdf
RR - Technicals 1.pdf
 
RJ
RJRJ
RJ
 
Ccall 4 q11_ing
Ccall 4 q11_ingCcall 4 q11_ing
Ccall 4 q11_ing
 
ITC 1QFY15 results largely in-line; buy
 ITC 1QFY15 results largely in-line; buy ITC 1QFY15 results largely in-line; buy
ITC 1QFY15 results largely in-line; buy
 

Mehr von IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNotes.com
 

Mehr von IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
 

Kürzlich hochgeladen

NO1 Certified kala jadu karne wale ka contact number kala jadu karne wale bab...
NO1 Certified kala jadu karne wale ka contact number kala jadu karne wale bab...NO1 Certified kala jadu karne wale ka contact number kala jadu karne wale bab...
NO1 Certified kala jadu karne wale ka contact number kala jadu karne wale bab...Amil baba
 
212MTAMount Durham University Bachelor's Diploma in Technology
212MTAMount Durham University Bachelor's Diploma in Technology212MTAMount Durham University Bachelor's Diploma in Technology
212MTAMount Durham University Bachelor's Diploma in Technologyz xss
 
Uae-NO1 Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
Uae-NO1 Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...Uae-NO1 Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
Uae-NO1 Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...Amil baba
 
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.pptAnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.pptPriyankaSharma89719
 
magnetic-pensions-a-new-blueprint-for-the-dc-landscape.pdf
magnetic-pensions-a-new-blueprint-for-the-dc-landscape.pdfmagnetic-pensions-a-new-blueprint-for-the-dc-landscape.pdf
magnetic-pensions-a-new-blueprint-for-the-dc-landscape.pdfHenry Tapper
 
Stock Market Brief Deck FOR 4/17 video.pdf
Stock Market Brief Deck FOR 4/17 video.pdfStock Market Brief Deck FOR 4/17 video.pdf
Stock Market Brief Deck FOR 4/17 video.pdfMichael Silva
 
《加拿大本地办假证-寻找办理Dalhousie毕业证和达尔豪斯大学毕业证书的中介代理》
《加拿大本地办假证-寻找办理Dalhousie毕业证和达尔豪斯大学毕业证书的中介代理》《加拿大本地办假证-寻找办理Dalhousie毕业证和达尔豪斯大学毕业证书的中介代理》
《加拿大本地办假证-寻找办理Dalhousie毕业证和达尔豪斯大学毕业证书的中介代理》rnrncn29
 
Economic Risk Factor Update: April 2024 [SlideShare]
Economic Risk Factor Update: April 2024 [SlideShare]Economic Risk Factor Update: April 2024 [SlideShare]
Economic Risk Factor Update: April 2024 [SlideShare]Commonwealth
 
Overview of Inkel Unlisted Shares Price.
Overview of Inkel Unlisted Shares Price.Overview of Inkel Unlisted Shares Price.
Overview of Inkel Unlisted Shares Price.Precize Formely Leadoff
 
『澳洲文凭』买科廷大学毕业证书成绩单办理澳洲Curtin文凭学位证书
『澳洲文凭』买科廷大学毕业证书成绩单办理澳洲Curtin文凭学位证书『澳洲文凭』买科廷大学毕业证书成绩单办理澳洲Curtin文凭学位证书
『澳洲文凭』买科廷大学毕业证书成绩单办理澳洲Curtin文凭学位证书rnrncn29
 
Bladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex
 
cost of capital questions financial management
cost of capital questions financial managementcost of capital questions financial management
cost of capital questions financial managementtanmayarora23
 
2024 Q1 Crypto Industry Report | CoinGecko
2024 Q1 Crypto Industry Report | CoinGecko2024 Q1 Crypto Industry Report | CoinGecko
2024 Q1 Crypto Industry Report | CoinGeckoCoinGecko
 
NO1 WorldWide Love marriage specialist baba ji Amil Baba Kala ilam powerful v...
NO1 WorldWide Love marriage specialist baba ji Amil Baba Kala ilam powerful v...NO1 WorldWide Love marriage specialist baba ji Amil Baba Kala ilam powerful v...
NO1 WorldWide Love marriage specialist baba ji Amil Baba Kala ilam powerful v...Amil baba
 
government_intervention_in_business_ownership[1].pdf
government_intervention_in_business_ownership[1].pdfgovernment_intervention_in_business_ownership[1].pdf
government_intervention_in_business_ownership[1].pdfshaunmashale756
 
NO1 Certified Black Magic Specialist Expert In Bahawalpur, Sargodha, Sialkot,...
NO1 Certified Black Magic Specialist Expert In Bahawalpur, Sargodha, Sialkot,...NO1 Certified Black Magic Specialist Expert In Bahawalpur, Sargodha, Sialkot,...
NO1 Certified Black Magic Specialist Expert In Bahawalpur, Sargodha, Sialkot,...Amil baba
 
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办fqiuho152
 
Role of Information and technology in banking and finance .pptx
Role of Information and technology in banking and finance .pptxRole of Information and technology in banking and finance .pptx
Role of Information and technology in banking and finance .pptxNarayaniTripathi2
 
The Triple Threat | Article on Global Resession | Harsh Kumar
The Triple Threat | Article on Global Resession | Harsh KumarThe Triple Threat | Article on Global Resession | Harsh Kumar
The Triple Threat | Article on Global Resession | Harsh KumarHarsh Kumar
 
The Inspirational Story of Julio Herrera Velutini - Global Finance Leader
The Inspirational Story of Julio Herrera Velutini - Global Finance LeaderThe Inspirational Story of Julio Herrera Velutini - Global Finance Leader
The Inspirational Story of Julio Herrera Velutini - Global Finance LeaderArianna Varetto
 

Kürzlich hochgeladen (20)

NO1 Certified kala jadu karne wale ka contact number kala jadu karne wale bab...
NO1 Certified kala jadu karne wale ka contact number kala jadu karne wale bab...NO1 Certified kala jadu karne wale ka contact number kala jadu karne wale bab...
NO1 Certified kala jadu karne wale ka contact number kala jadu karne wale bab...
 
212MTAMount Durham University Bachelor's Diploma in Technology
212MTAMount Durham University Bachelor's Diploma in Technology212MTAMount Durham University Bachelor's Diploma in Technology
212MTAMount Durham University Bachelor's Diploma in Technology
 
Uae-NO1 Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
Uae-NO1 Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...Uae-NO1 Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
Uae-NO1 Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.pptAnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
AnyConv.com__FSS Advance Retail & Distribution - 15.06.17.ppt
 
magnetic-pensions-a-new-blueprint-for-the-dc-landscape.pdf
magnetic-pensions-a-new-blueprint-for-the-dc-landscape.pdfmagnetic-pensions-a-new-blueprint-for-the-dc-landscape.pdf
magnetic-pensions-a-new-blueprint-for-the-dc-landscape.pdf
 
Stock Market Brief Deck FOR 4/17 video.pdf
Stock Market Brief Deck FOR 4/17 video.pdfStock Market Brief Deck FOR 4/17 video.pdf
Stock Market Brief Deck FOR 4/17 video.pdf
 
《加拿大本地办假证-寻找办理Dalhousie毕业证和达尔豪斯大学毕业证书的中介代理》
《加拿大本地办假证-寻找办理Dalhousie毕业证和达尔豪斯大学毕业证书的中介代理》《加拿大本地办假证-寻找办理Dalhousie毕业证和达尔豪斯大学毕业证书的中介代理》
《加拿大本地办假证-寻找办理Dalhousie毕业证和达尔豪斯大学毕业证书的中介代理》
 
Economic Risk Factor Update: April 2024 [SlideShare]
Economic Risk Factor Update: April 2024 [SlideShare]Economic Risk Factor Update: April 2024 [SlideShare]
Economic Risk Factor Update: April 2024 [SlideShare]
 
Overview of Inkel Unlisted Shares Price.
Overview of Inkel Unlisted Shares Price.Overview of Inkel Unlisted Shares Price.
Overview of Inkel Unlisted Shares Price.
 
『澳洲文凭』买科廷大学毕业证书成绩单办理澳洲Curtin文凭学位证书
『澳洲文凭』买科廷大学毕业证书成绩单办理澳洲Curtin文凭学位证书『澳洲文凭』买科廷大学毕业证书成绩单办理澳洲Curtin文凭学位证书
『澳洲文凭』买科廷大学毕业证书成绩单办理澳洲Curtin文凭学位证书
 
Bladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results PresentationBladex 1Q24 Earning Results Presentation
Bladex 1Q24 Earning Results Presentation
 
cost of capital questions financial management
cost of capital questions financial managementcost of capital questions financial management
cost of capital questions financial management
 
2024 Q1 Crypto Industry Report | CoinGecko
2024 Q1 Crypto Industry Report | CoinGecko2024 Q1 Crypto Industry Report | CoinGecko
2024 Q1 Crypto Industry Report | CoinGecko
 
NO1 WorldWide Love marriage specialist baba ji Amil Baba Kala ilam powerful v...
NO1 WorldWide Love marriage specialist baba ji Amil Baba Kala ilam powerful v...NO1 WorldWide Love marriage specialist baba ji Amil Baba Kala ilam powerful v...
NO1 WorldWide Love marriage specialist baba ji Amil Baba Kala ilam powerful v...
 
government_intervention_in_business_ownership[1].pdf
government_intervention_in_business_ownership[1].pdfgovernment_intervention_in_business_ownership[1].pdf
government_intervention_in_business_ownership[1].pdf
 
NO1 Certified Black Magic Specialist Expert In Bahawalpur, Sargodha, Sialkot,...
NO1 Certified Black Magic Specialist Expert In Bahawalpur, Sargodha, Sialkot,...NO1 Certified Black Magic Specialist Expert In Bahawalpur, Sargodha, Sialkot,...
NO1 Certified Black Magic Specialist Expert In Bahawalpur, Sargodha, Sialkot,...
 
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
 
Role of Information and technology in banking and finance .pptx
Role of Information and technology in banking and finance .pptxRole of Information and technology in banking and finance .pptx
Role of Information and technology in banking and finance .pptx
 
The Triple Threat | Article on Global Resession | Harsh Kumar
The Triple Threat | Article on Global Resession | Harsh KumarThe Triple Threat | Article on Global Resession | Harsh Kumar
The Triple Threat | Article on Global Resession | Harsh Kumar
 
The Inspirational Story of Julio Herrera Velutini - Global Finance Leader
The Inspirational Story of Julio Herrera Velutini - Global Finance LeaderThe Inspirational Story of Julio Herrera Velutini - Global Finance Leader
The Inspirational Story of Julio Herrera Velutini - Global Finance Leader
 

CCL Products: Standalone net sales grew by 4.2% y-o-y; Accumulate

  • 1. India Research Sector: FMCG CCL Products Ltd. The company recently released its Q1FY15 results. The results are a testimony to the management’s strategy of profitable growth. The company has enumerated the following focal points which will drive growth in the future: o Firstly in domestic markets the company plans to expand its presence of its retail brand ‘Continental Coffee”. Priced at a premium this is offering is not a head along war with Nestle & HUL. The product is a freeze dried offering as compared to the existing offerings of instant coffee in India (are primarily spray dried coffee). Over the next 2 to 3 years CCL wants ~ 15% of the existing capacity in India to be used for domestic markets.The domestic markets are much more profitable as well. o Secondly, in Vietnam the company is expected to reach 50% capacity utilization in FY15. Strong Demand coupled with cost savings on account of local procurement of raw bean has enabled the company to be competitively present in the market. Q1 saw profit out of Vietnam operations. These operations enjoy a 4 year tax holiday and as the contribution from this region increases going forward the tax saving will enable profits to grow at a higher rate.The company plans to double the capacity to 20,000 MT for the Vietnamese operations next fiscal with minimum capex as the foundation was already setup when the first has was being setup. This too will add volumes and scale to CCL operations over the next 2 years. Result Highlights: Standalone net sales grew by 4.2% YOY to `132.6 crs driven primarily by volumes.Volumes were up 9.6% to 3125 MT from 2850 MT corresponding quarter last year. Being a lean quarter (summer months globally) the mix was tilted towards the sub-premium quality of coffee. Realizations per kg were 5% lower at `424/kg vs. `447 per/kg. On a consolidated basis net sales grew by 29.5% to `175.6 crs. Subsidiaries sales were up 400%YOY to `43 crs. Vietnamese operations picked up passed with production of ~1150 MT this quarter and volumes sale of ~900 MT. Realizations were in the range of `400-440/ kg in Vietnam. For FY15 the company expects consolidated volumes of ~20,000 MT in which Vietnam will contribute ~5000 MT. We expect topline to grow at ~20-22% CAGR over the next 2 to 3 years. On the operating level the mix adversely impacted the margins. Operating profit in standalone operations was down from `27.7 crs to `25.3 crs. Operating margins contracted by 280 bps to 19%. Seasonality in demand in export markets as well as Re./$ translation impacted profitability growth. . Consolidated EBIDTA for Q1FY15 grew by 19.5% to `36 crs with margins contracting by 170 bps to 20.5%. Margins in the subsidiaries were at ~25% with absolute level operating profit at ~`10 crs. On the PAT Level standalone operations was flat at `15.7 crs as tax rate for the quarter was Result Update Q1FY15 Date 30th July 2014 CMP `69.2/- 52 week High / Low `75.7/`24.1 Equity Cap (current) `26.6 crs FaceValue `2/- Mkt. Capitalization `920 crs. BSE SENSEX 25,991.23 NSE - NIFTY 7,748.70 NSE Code CCL Bloomberg Code CCL IN BSE Code 519600 Shareholding Pattern @ 30-06-14 Promoters 44.54% FII & DFI 9.17% Public & Others 46.30% 3-MTS 6-MTS 1-YR CCL 28.1% 57.2% 172.0% Sensex 15.7% 24.1% 37.6% Nifty 15.4% 24.5% 39.6% Brief Financials FY13A FY14A FY15E Net Sales 650.7 716.8 862.2 Sales growth 10.2% 20.3% EBITDA 121.3 143.1 180.5 EBITDAM 18.6% 20.0% 20.9% PAT 47.5 64.4 96.2 EPS 3.6 4.8 7.2 P/E (x) 19.7 14.5 9.6 Nilesh Doshi Tel: +9122-66638950 Nilesh.doshi@tssl.in Accumulate
  • 2. CCL Products Ltd. – Q1FY15 2 30th July2014 India Research Sector: FMCG lower. Consolidated PAT grew much faster at 587% to `20 crs. on the ack of Vietnamese operations breaking even on the PAT level. We expect Operating profit margins to remain in range of 19-20%. PAT will grow much faster as Vietnamese operations ramp up and become PAT positive.The tax holiday will further perk up growth. We expect PAT to grow by ~35-40% for the next 2 to 3 years. Outlook &Valuations: We believe the growth levers for CLL products to be well placed. The company’s focus on growing its presence in the domestic market with a strong brand coupled with ramp-up ofVietnamese operations will pave the road to healthy profitable growth for the next 2-3 years. At the CMP of ````69.2/- the stock trades at 9.6x its FY15E estimated EPS of ````7.2/-. We recommend investors to ACCUMULATE the stock. Quarterly Results
  • 3. CCL Products Ltd. – Q1FY15 3 30th July2014 India Research Sector: FMCG (` Cr.) (YE March 31) STANDALONE CONSOLIDATED Q1FY 15 Q1FY 14 % Chg. FY14 FY13 % Chg. Q1FY 15 Q1FY 14 % Chg. FY14 FY13 % Chg. Net Sales 132.6 127.2 4.2% 611.1 584.8 4.5% 175.6 135.6 29.5% 716.8 650.7 10.2% Other operational Income Total Oper. Income(TOI) 132.6 127.2 4.2% 611.1 584.8 4.5% 175.6 135.6 29.5% 716.8 650.7 10.2% Raw Materials Cons. 84.1 72.1 16.6% 357.3 353.3 1.1% 114.1 82.1 39.0% 420.0 396.7 5.9% % to TOI 63.4% 56.7% 58.5% 60.4% 65.0% 60.6% 58.6% 61.0% Stock adj. (-)Inc / (+)Dec -2.7 -5.8 -53.6% -2.1 -0.4 445.6% -8.5 -13.5 -37.4% 5.1 -12.2 % to TOI -2.0% -4.5% -0.3% -0.1% -4.8% -10.0% 0.7% -1.9% Net Raw Mat adj. for stock 81.4 66.4 22.7% 355.2 352.9 0.7% 105.7 68.6 54.0% 425.1 384.5 10.5% % to TOI 61.4% 52.2% 58.1% 60.3% 60.2% 50.6% 59.3% 59.1% Personnel 5.1 4.7 7.3% 21.9 17.5 25.2% 6.1 5.5 10.0% 25.8 21.2 21.7% % to TOI 3.8% 3.7% 3.6% 3.0% 3.5% 4.1% 3.6% 3.3% Packing Material Consumed 6.7 7.2 -7.7% 33.0 32.8 0.5% 7.3 7.4 -1.7% 34.6 33.8 2.3% % to TOI 5.0% 5.7% 5.4% 5.6% 4.2% 5.5% 4.8% 5.2% Power & Fuel 7.9 7.6 3.5% 38.7 40.0 -3.1% 10.5 8.6 22.3% 45.6 44.1 3.5% % to TOI 5.9% 6.0% 6.3% 6.8% 6.0% 6.4% 6.4% 6.8% Other expenses 6.4 13.6 -53.4% 34.8 34.5 1.0% 10.1 15.3 -34.4% 42.6 45.8 -7.0% % to TOI 4.8% 10.7% 5.7% 5.9% 5.7% 11.3% 5.9% 7.0% Total expenditure 107.3 99.5 7.9% 483.6 477.6 1.3% 139.7 105.5 32.4% 573.7 529.4 8.4% Operating Profit 25.3 27.7 -8.8% 127.5 107.3 18.9% 36.0 30.1 19.5% 143.1 121.3 18.0% OPM (%) 19.0% 21.8% 20.9% 18.3% 20.5% 22.2% 20.0% 18.6% Non-Operating Income 0.4 0.1 278.1% 0.9 1.4 -35.8% 0.9 0.2 356.5% 2.6 1.9 40.2% Interest 1.9 2.1 -13.5% 7.3 12.0 -39.1% 4.2 3.8 10.0% 17.1 20.7 -17.4% Depreciation 2.4 3.5 -31.1% 13.0 15.9 -18.4% 6.7 6.8 -2.0% 29.1 28.6 1.6% PBT before Extra- ord 21.4 22.2 -3.5% 108.2 80.8 33.9% 25.9 19.6 32.1% 99.6 73.9 34.8% PBT (%) 16.1% 17.4% 17.7% 13.8% 14.7% 14.4% 13.9% 11.4% PBT 21.4 22.2 -3.5% 108.2 80.8 33.9% 25.9 19.6 32.1% 99.6 73.9 34.8% Prov. for Tax- Cur 5.8 6.6 -11.8% 34.5 25.1 37.7% 5.8 6.6 -11.8% 34.7 25.2 37.5% Tax/PBT (%) 27.2% 29.8% 31.9% 31.0% 22.5% 33.7% 34.9% 34.2% Profit after Cur. Tax 15.6 15.6 0.0% 73.7 55.8 32.1% 20.1 13.0 54.4% 64.9 48.6 33.3% Prov. for Tax- Def -0.1 0.3 - 154.7% 0.4 1.2 -62.4% -0.1 0.3 - 154.0% 0.4 1.2 -62.4% Profit after Tax 15.7 15.3 2.6% 73.3 54.6 34.2% 20.2 12.7 58.7% 64.4 47.5 35.7% PAT (%) 11.84% 12.03% 11.99% 9.33% 11.51% 9.39% 8.99% 7.29% Share of Profit/(Loss) of Associates Minority Interest Reported PAT 15.7 15.3 2.6% 73.3 54.6 34.2% 20.2 12.7 58.7% 64.4 47.5 35.7% PAT (adj. For extraord) 15.7 15.3 2.6% 73.3 54.6 34.2% 20.2 12.7 58.7% 64.4 47.5 35.7% Face Value 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Equity Share capital 26.6 26.6 26.6 26.6 26.6 26.6 26.6 26.6 No. of shares (in crs.) 13.3 13.3 13.3 13.3 13.3 13.3 13.3 13.3 EPS (````) 1.2 1.2 2.6% 5.5 4.1 34.2% 1.5 1.0 58.7% 4.8 3.6 35.7%
  • 4. CCL Products Ltd. – Q1FY15 4 30th July2014 India Research Sector: FMCG Team Analyst Designation Sector Email Telephone Nilesh Doshi President (Research) nilesh.doshi@tssl.in +9122-6633 8950 ShivaniV.Vishwanathan Sr. Research Analyst FMCG shivani.mehra@tssl.in +9122-6663 8956 Nisha Harchekar Sr. Research Analyst Chemicals nishaharchekar@way2wealth.com +9122-6146 2952 Institutional Dealing Designation Email Telephone Ajay Prabhudesai AssistantVice President ajay.prabhudesai@tssl.in +9122-4027 8930 Mitul Doshi Senior Executive mitul.doshi@tssl.in +9122-4027 8932 GautamVyas Institutional Sales Trader gautam.vyas@tssl.in +9122-4027 8934 Corporate Office: 3rd Floor, Hincon House,Tower - B, 247 Park, L.B.S. Marg,Vikhroli (W), Mumbai, Maharashtra – 400083, India. Tel No. 91-22 – 6663 8900 Email: research@tssl.in website: www.technoworld.in, www.way2wealth.com Strictly for Private Circulation only.All rights reserved. ©Techno Shares & Stocks Ltd & Way2Wealth Brokers Pvt. Ltd. DISCLAIMER: This information & opinions in this report have been prepared by TECHNO SHARES & STOCKS LTD &WAY2WEALTH BROKERS PVT. LTD.The report & the information contained herein are strictly confidential and meant solely for the authorized recipient and may be restricted by law or regulation in certain countries.This report is for information purposes only for the authorized reader and does not construe to be any investment, legal or taxation advice. This report is based on the information obtained from public sources and sources believed to be reliable, however, no warranty, express or implied, are given for the accuracy or correctness of the same and it should not be construed as such. It is also not intended as an offer or solicitation for the purchase and sale of any financial instrument. Techno Shares & Stocks Ltd &Way2Wealth Brokers Pvt. Ltd. and/or its subsidiaries and/or directors, employees, officers or associates – including the persons involved in the preparation/issuance of this report may have (a) from time to time, any interest or positions (buy/sell etc.) – financial (including in derivatives/commodities market) or otherwise in the companies/securities covered/mentioned in this report and may have acted upon the information &/or (b) been engaged in any other transaction, commercial or otherwise, in respect of the companies/securities covered in this report, like earning brokerage, commission or act as a market maker &/or (c) performed or may seek to perform any merchant/investment banking services for such companies or act as advisor or lender/borrower to such companies &/or (d) have other possible conflict of interest with respect to any recommendation or any information/opinions that could affect the objectivity of this report. As a result, the authorized recipients of this report should rely on their own investigations and analysis & seek professional advice. Any action taken by any one solely on the basis of the information contained herein is their own responsibility alone and Techno Shares & Stocks Ltd,Way2Wealth Brokers Pvt. Ltd. and its subsidiaries or its directors, employees or associates will not be liable in any manner whatsoever for the consequences of such action taken. No data/information contained in this report shall be copied, forwarded, transmitted or distributed, in part or in whole, in any form or in any media, without the previous written consent ofTechno Shares & Stocks Ltd. &Way2Wealth Brokers Pvt. Ltd.